Safety of a non-viral plasmid-encoding dual isoforms of hepatocyte growth factor in critical limb ischemia patients: a phase I study.
about
Combined transfer of human VEGF165 and HGF genes renders potent angiogenic effect in ischemic skeletal musclepCMV-vegf165 Intramuscular Gene Transfer is an Effective Method of Treatment for Patients With Chronic Lower Limb Ischemia.Optimizing in vivo gene transfer into mouse corpus cavernosum by use of surface electroporationDouble-blind, placebo-controlled study of HGF gene therapy in diabetic neuropathy.A review of the pathophysiology and potential biomarkers for peripheral artery disease.Vascular regeneration by pinpoint delivery of growth factors using a microcatheter reservoir system in a rabbit hind-limb ischemia model.Modulating the vascular response to limb ischemia: angiogenic and cell therapies.Phase 1/2 open-label dose-escalation study of plasmid DNA expressing two isoforms of hepatocyte growth factor in patients with painful diabetic peripheral neuropathy.Therapeutic angiogenesis in critical limb ischemia.Medical management of critical limb ischaemia: where do we stand today?Beperminogene perplasmid for the treatment of critical limb ischemia.Results of an International Postmarketing Surveillance Study of pl-VEGF165 Safety and Efficacy in 210 Patients with Peripheral Arterial DiseaseOpen label study to assess the safety of VM202 in subjects with amyotrophic lateral sclerosis.Trimodal rescue of hind limb ischemia with growth factors, cells, and nanocarriers: fundamentals to clinical trials.Safety and efficacy of plasmid DNA expressing two isoforms of hepatocyte growth factor in patients with critical limb ischemia.Growth factors released from gelatin hydrogel microspheres increase new neurons in the adult mouse brain.Gene therapy and cell-based therapies for therapeutic angiogenesis in peripheral artery disease.A novel mechanism in maggot debridement therapy: protease in excretion/secretion promotes hepatocyte growth factor production.Intramyocardial transfer of hepatocyte growth factor as an adjunct to CABG: phase I clinical study.Gene therapy for neuropathic pain induced by spared nerve injury with naked plasmid encoding hepatocyte growth factor.Hepatocyte Growth Factor Isoforms in Tissue Repair, Cancer, and Fibrotic Remodeling.Glycoprotein nonmetastatic melanoma protein B ameliorates skeletal muscle lesions in a SOD1G93A mouse model of amyotrophic lateral sclerosis.
P2860
Q28728494-0166D255-400C-49F0-BCA7-D811E31D376BQ34467088-636527AC-90EB-4A05-B239-5AD07505894AQ35164806-00DAD980-78F7-4777-A4E1-C5A6DA269095Q35619182-EBAFF286-2DC6-4339-B50C-3953E6E2F1A3Q35723731-5DCE51AF-A543-4B00-8EE0-DA323918B67CQ36285698-CCC34C04-669E-4506-8CF8-09802EFB56DCQ36908997-E9C8454E-39B2-4B6C-A9DE-CCCB51BEF68EQ36915162-3944D5AE-0383-4D2A-BB93-D9CB3788ED34Q37142832-766DBD66-2C02-448C-AAB0-123ECB342075Q38116561-5ECF3604-1F36-4329-8344-E2FE289D2ACEQ38246211-F4DA95F9-ADA9-4CAC-A14B-D028522D666CQ38382866-18034537-0E9E-4914-B62D-4857A0C574E2Q38760817-89445782-97A4-4ACB-BD66-132732F6FA1EQ39240834-6FA12498-A6C9-4027-BE8D-3E360E4B5D5BQ40230056-FF4C7AF0-765A-40E6-876E-43AA7F15C3D7Q41777840-B3FA3BB5-3B2E-4C12-9D79-23C03302BBF5Q42181707-D30F272E-9A57-433C-BCEF-B37653DAB146Q42806275-CD6EADDA-4C9C-4B9D-8749-545E005D3E65Q44611913-ACB09330-9CDC-42EB-9C90-9FD16887E23AQ45873482-702EB15E-EE3F-4171-A930-8CF839975870Q50977853-CB6DC40D-A12E-43A0-91A2-A8160959E216Q53441459-89EFB001-6030-4DC8-A60C-3EABA62DCA81
P2860
Safety of a non-viral plasmid-encoding dual isoforms of hepatocyte growth factor in critical limb ischemia patients: a phase I study.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Safety of a non-viral plasmid- ...... mia patients: a phase I study.
@en
Safety of a non-viral plasmid- ...... mia patients: a phase I study.
@nl
type
label
Safety of a non-viral plasmid- ...... mia patients: a phase I study.
@en
Safety of a non-viral plasmid- ...... mia patients: a phase I study.
@nl
prefLabel
Safety of a non-viral plasmid- ...... mia patients: a phase I study.
@en
Safety of a non-viral plasmid- ...... mia patients: a phase I study.
@nl
P2093
P2860
P356
P1433
P1476
Safety of a non-viral plasmid- ...... emia patients: a phase I study
@en
P2093
A T Hirsch
W D McMillan
P2860
P2888
P304
P356
10.1038/GT.2011.21
P50
P577
2011-03-24T00:00:00Z
P6179
1031566312